Gelesis Obtains $2,555,000 New Funding

  • Feed Type
  • Date
    6/9/2011
  • Company Name
    Gelesis
  • Mailing Address
    222 Berkeley St Boston, MA 02116
  • Company Description
    Gelesis is a Boston-based company developing a breakthrough treatment for obesity and other related co-morbidities.
  • Website
    http://www.gelesis.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,555,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed